A potential hidden source of hepatitis c infection among noninjecting drug users

Journal of Psychoactive Drugs

Volumn 35, Issue 4, 2003, Pages 455-460

  McMahon, James M ^a   Tortu, Stephanie ^b  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

HCV transmission; Hepatitis C virus; Intranasal drug use; Noninjection drug use; Review

Indexed keywords

CHRONIC LIVER DISEASE; DRUG ABUSE; DRUG DEPENDENCE; EPIDEMIOLOGICAL DATA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRANASAL DRUG ADMINISTRATION; PATHOGENESIS; PREVALENCE; PROSPECTIVE STUDY; REVIEW; SYRINGE; UNITED STATES; VIRUS TRANSMISSION;

EID: 0347986898     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2003.10400492     Document Type: Article

References (54)

1. Aceti, A.; Taliani, G.; Sorice, M. & Arnendolea, M.M. 1992. HCV and Sjogren's syndrome. L&ncet 339: 1425-26.
2. Alter, M.J. 1999. Hepatitis C virus infection in the United States. Journal of Hepatology 31 (Suppl 1): 88-91.
3. Alter, M.J. 1997. Epidemiology of hepatitis C. Journal of Hepatology 26 (3 Suppl I): 62S-65S.
4. Alter, M.J.; Kruszon-Moran, M.S.; Nainan, O.V.; McQuillan, G.M.; Gao, F.; Moyer, L.A.; Kaslow, R.A. & Margolis, H.S. 1999. The prevalence of hepatitis C virus infection in the United States. 19881994. New England Journal of Medicine 341: 556-62.
5. Alter, H.J.; Conry-Cantilena, C.; Melpolder, J.; Tan, D.; Van Raden, M.; Herion, D.; Lau, D. & Hoofnagle, J.H. 1997. Hepatitis C in asymptomatic blood donors. Journal of Hepatology 26 (3 Suppl 1): 29S-33S.
6. Alter, M.J.; Margolis, H.; Krawczynski Judson F.N.; Mares, A.; Alexander, W.J.; Hu P.Y.; Miller, J.K.; Gerber, M.A.; Sampliner, R.; Meeks, E.L. & Beach, M.J. 1992. The natural history of community acquired hepatitis C in the United States. New England Journal of Medicine 327: 1899-905.
7. Alter, M.J.; Coleman, P.J.; Alexander, W.J.; Kramer, E.; Miller, J.K.; Mandel, E.; Hadler, S.C. & Margolis, H.S. 1989. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. Journal of the American Medical Association 262 (9): 1201-05.
8. Arrieta, J.J.; Rodriguez-Inigo, E.; Ortiz-Movilla, N.; Bartolome, J.; Pardo, M.; Manzarbeitia, F.; Oliva, H.; Macias, D.M. & Carreno, V. 2001. In situ detection of hepatitis C virus RNA in salivary glands. American Journal of Pathology 158 (1): 259-64.
9. Bi asi, D.; Colombari, R.; Achille, A.; Carletto, A.; Caramashi, P.; Corrocher, R. & Bambara L.M. 1995. HCV RNA detection in parotid gland biopsy in a patient with chronic hepatitis C virus liver disease. Acta Gastro-Enterologica Belgica 58 (5-6): 465-69.
10. Caldwell, S.H.; Dickson, R.C.; Driscoll, C. & Sue, M. 1995. Sexual, vertical and household transmission of hepatitis C. Virginia Medical Quarterly 122 (4): 270-74.
11. Centers forDisease Control and Prevention. 2002. Hepatitis Surveillance Report No. 57. Atlanta, Georgia: CDC.
12. Centers for Disease Control and Prevention. 1998. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic diseases. Morbidity and Mortality Weekly Report. 47 (No. RR19): 1-39.
13. Chen, M.; Yun, Z.B.; Sallberg, M.; Schvarcz, R.; Bergquist, I.; Berglund, H.B. & Sonnerborg, A. 1995. Detection of hepatitis C virus RNA in the cell fraction of saliva before and after oral surgery. Journal of Medical Virology 45: 223-26.
14. Conry-Cantilena, C.; VanRaden, M.; Gibble, J.; Melpolder, J.; Shakil, A.O.; Viladomiu, L.; Cheung, L.; DiBisceglie, A.; Hoofnagle, J.; Shih, J.W.; Kaslow, R.; Ness, P. & Alter, H.J. 1996. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. New England Journal of Medicine 334 (26): 1691-96.
15. Darke, S. 1998. Self-report among injecting drug users: A review. Drug and Alcohol Dependence 51 (3): 253-63.
16. Ebeling, F. 1998. Epidemiology of the hepatitis C virus. Vox Sanguinis 74 (Suppl 2): 143-46.
17. Feehan, H.F. & Mancusi Ungaro, A. 1976. The use ofcocaine as a topical anesthetic in nasal surgery. A survey report. Plastic and Reconstructive Surgery 57 (1): 62-5.
18. Flamm, S.L.; Parker, R.A. & Chopra, S. 1998. Risk factors associated with chronic hepatitis C virus infection: Limited frequency of an unidentified source of transmission. American Journal of Gastroenterology 93 (4): 597-600.
19. Goldstein, M.; Neaigus, A.; Jose, B.; defonso, G.; Curtis, R. & Friedman, S.R. 1995. Self-reports of HIV risk behavior by injecting drug users: Are they reliable? Addiction 90 (8): 1097-104.
20. Green, S.T.; Mohsen, A.H.; McKendrick, M.W.; Dawes, Y.; Prakasam, S.F.; Walberg, R. & Schmid, M.L. 2001. Potential for hepatitis C transmission among non-needle/syringe sharing Sheffield drug injectors through the sharing of drug preparation paraphernalia. Community Diseases of Public Health 4 (1): 38-41.
21. Hagan, H.; Thiede, H.; Weiss, N.S.; Hopkins, S.G.; Duchin, J.S. & Alexander, E. R. 2001. Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health 91: 42-46.
22. Hahn, J.A.; Page-Shafer, K.; Lum, P.J.; Bourgois, P.; Stein, E.; Evans, J.L.; Busch, M.P.; Tobler L.H.; Phelps, B. & Moss, A.R. 2002. Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. Journal of Infectious Diseases 186 (2): 1558-64.
23. Hermida, M.; Ferreiro, M.C.; Barral, S.; Laredo, R.; Castro, A. & Diz Dios, P. 2002. Detection of HCV RNA in saliva of patients with hepatitis C virus infection by using a highly sensitive test. Journal of Virological Methods 101 (1-2): 29-35.
24. Hindy, A.M.; Abdelhaleem, E.S. & Aly, R.H. 1995. Hepatitis B and C viruses among Egyptian dentists. Egyptian Dental Journal 41 (3): 1217-26.
25. Holland, P. V. 1996. Viral infections and the blood supply. New England Journal of Medicine 334 (26): 1734-35.
26. Kage, M.; Ogasawara, S.; Kosai, K.; Nakashima, E.; Shimamatsu, K.; Kojiro, M.; Kimura, A.; Fujisawa, T.; Matsukuma, Y.; Ito, Y.; Kondo, S.; Kawano, K. & Sata, M. 1997. Hepatitis C virus RNA present in saliva but absent in breast-milk of the hepatitis C carrier mother. Journal of Gastroenterology and Hepatology 12(7): 518-21.
27. Klein, R.S.; Freeman, K.; Taylor, P.E. & Stevens, C.E. 1991. Occupational risk for hepatitis C virus infection among New York City dentists. Lancet 338 (8782-8783): 1539-42.
28. Kleinman, S.H. & Busch, M.P 2000. The risks of transfusion-transmitted infection: Direct estimation and mathematical modeling. Baillieres Best Practice & Research. Clinical Haematology 13 (4): 631-49.
29. Ladron-de Guevara, L.; Gomez, N.; Vazquez-Cantarell, M.; Garcia-Mendez, S. & Di Silvio, M. 2002. Revista de Gastroenterologia de Mexico 67: 11-16.
30. Liou, T.C.; Chang, T.T.; Young, K.C.; Lin, X.Z.; Lin, C.Y. & Wu, H.L. 1992. Detection of HCV RNA in saliva, urine, seminal fluid, and ascites. Journal of Medical Virology 37 (3): 197-202.
31. Maticic, M.; Poljak, M.; Kramar, B.; Seme, K.; Brinovec, V.; Meglic-Volkar, J.; Zakotnik, B. & Skaleric, U. 2001. Detection of hepatitis C virus RNA from gingival crevicular fluid and its relation to virus presence in saliva. Journal of Periodontology 72 (1): 11-6.
32. McElrath, K.; Chitwood, D.D.; Griffin, D.K. & Comerford, M. 1994. The consistency of self-reported HIV risk behavior among injection drug users. American Journal of Public Health 84 (12): 1965-70.
33. McQuillan, G.M.; Alter, M.J.; Moyer, L.A.; Lambert, S.B. & Margolis, H.S. 1997. A population-based serologic study of hepatitis C virus infection in the United States. In: M. Rizzetto; R.H. Purcell.; J.L. Gerin. & G. Verne (Eds.) Viral Hepatitis and Liver Disease. Turin, Italy: Edizioni Minerva Medica.
34. Memon, M.I. & Memon, M.A. 2002. Hepatitis C: An epidemiological review. Journal of Viral Hepatitis 9 (2): 84-100.
35. Murphy, E.L.; Bryzman, S.M.; Glynn, S.A.; Ameli, D.l.; Thomson, R.A.; Williams, A.E.; Nass, C.C.; Ownby, H.E.; Schreiber, G.B.; Kong, F.; Neal, K.R. & Nemo, G.J. 2000. Risk factors for hepatitis C virus infection in United States blood donors. Journal of Hepatology 31 (3): 756-62.
36. Nowicki, M.J. & Balistreri, W.F. 1995. The hepatitis C virus: Identification, epidemiology, and clinical controversies. Journal of Pediatric Gastroenterology and Nutrition 20 (3): 248-74.
37. Olubuyide, I.O.; Ola, S.O.; Aliyu, B.; Dosumu, O.O.; Arotiba, J.T.; Olaleye, O.A.; Odaibo, G.N.; Odemuyiwa, S.O. & Olawuyi, F. 1997. Prevalence and epidemiological characteristics of hepatitis B and C infections among doctors and dentists in Nigeria. East African Medical Journal 74 (6): 357-61.
38. Porter, S.R. & Lodi, G. 1996. Hepatitis C virus (HCV)—an occupational risk to dentists? British Dental Journal 180 (12): 473-74.
39. Rey, D.; Fritsch, S.; Schmitt, C.; Meyer, P.; Lang, J.M. & Stoll-Keller, F. 2001. Quantitation ofhepatitis C virus RNA in saliva and serum of patients coinfected with HCV and human immunodeficiency virus. Journal of Virological Methods 63 (2): 117-19.
40. Robinson, G.M.; Reynolds, J.N. & Robinson, B.J. 1995. Hepatitis C prevalence and needle/syringe sharing behaviours in recent onset injecting drug users. New Zealand Medical Journal 108 (996): 103-05.
41. Roy, E.; Haley, N.; Leclerc, P.; Boivin, J.F.; Cedras, L. & Vincelette, J. 2001. Risk factors for hepatitis C virus infection among street youths. Canadian Medical Association Journal 165 (5): 557-60.
42. Schwartz, R.H.; Estroff, T.; Fairbanks, D.N. & Hoffmann, N.G. 1989. Nasal symptoms associated with cocaineabuse during adolescence. Archives of Otolaryngology-Head & Neck Surgery 115 (1): 6364.
43. Smith, J.C.; Kacker, A. & Anand, VK. 2002. Midline nasal and hard palate destruction in cocaine abusers and cocaine's role in rhinologic practice. Ear, Nose, and Throat Journal 81 (3): 172-77.
44. Taliani, G.; Celestino, D.; Badolato, M.C.; Pennica, A.; Bozza, A.; Poliandri, G.; Riccieri V.; Benfari, G.; Sebastiani, A.; De Bac, C.; Quaranta, G. & Aceti, A. 1997. Hepatitis C virus infection of salivary gland epithelial cells. Lack of evidence. Journal of Hepatology 26 (6): 1200-06.
45. Tang, Z.; Yang, D.; Hao, L.; Tang, Z.; Huang, Y. & Wang, S. 1996. Detection and significance of HCV RNA in saliva, seminal fluid and vaginal discharge in patients with hepatitis C. Journal ofTongji Medical University 16 (1): 11-3, 24.
46. Terrault, N.A. 2002. Sexual activity as a risk factor for hepatitis C. Journal of Hepatology 36 (5): S99-S105.
47. Thorpe, L.E.; Ouellet, L.J.; Hershow, R.; Bailey, S.L.; Williams, I.T.; Williamson, J.; Monterroso, E.R. & Garfein, R.S. 2002. Risk of hepatitis C virus infection among young adult injection drog users who share injection equipment. American Journal Epidemiology 155 (7): 645-53.
48. Tibbs, C.J. 1995. Methods of transmission of hepatitis C. Journal of Viral Hepatitis 2: 113-19.
49. Tortu, S.; McMahon, J.M.; Pouget, E.R. & Hamid, R. In press. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Substance Use and Misuse.
50. Tortu, S.; Neaigus, A.; McMahon, J.M. & Hagen, D. 2001. Hepatitis C among noninjecting drug users: A report. Substance Use & Misuse 36 (4): 523-34.
51. Tortu, S.; McMahon, J.M.; Hamid, R. & Neaigus, A. 2000. Drug-using women's sexual risk: An event analysis. AIDS andBehavior 4 (4): 329-40.
52. Wejstal, R. 1999. Sexual transmission of hepatitis C virus. Journal of Hepatology 31 (Suppl 1): 92-95.
53. Yee, L.J.; Weiss, H.L.; Langner, R.G.; Herrera, J.; Kaslow, R.A. & van Leeuwen, D.J. 2001. Risk factors for acquisition of hepatitis C virus infection: A case series and potential implications for disease surveillance. BMC Infectious Diseases 1 (1): 8.
54. Zeuzem, S.; Teuber, G.; Lee, J.H.; Reuster, B. & Roth, W.K. 1996. Risk factors for the transmission of hepatitis C. Journal of Hepatology 24 (Suppl 2): 3-10.